194 related articles for article (PubMed ID: 33066540)
21. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
22. A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
Chang LA; Phung E; Crank MC; Morabito KM; Villafana T; Dubovsky F; Falloon J; Esser MT; Lin BC; Chen GL; Graham BS; Ruckwardt TJ
Sci Transl Med; 2022 Dec; 14(676):eade0424. PubMed ID: 36542692
[TBL] [Abstract][Full Text] [Related]
23. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
[TBL] [Abstract][Full Text] [Related]
24. Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
Sastry M; Zhang B; Chen M; Joyce MG; Kong WP; Chuang GY; Ko K; Kumar A; Silacci C; Thom M; Salazar AM; Corti D; Lanzavecchia A; Taylor G; Mascola JR; Graham BS; Kwong PD
PLoS One; 2017; 12(10):e0186854. PubMed ID: 29073183
[TBL] [Abstract][Full Text] [Related]
25. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
Harshbarger W; Abeyrathne PD; Tian S; Huang Y; Chandramouli S; Bottomley MJ; Malito E
MAbs; 2021; 13(1):1955812. PubMed ID: 34420474
[TBL] [Abstract][Full Text] [Related]
26. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
27. The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice.
Huang L; Liu MQ; Wan CQ; Cheng NN; Su YB; Zheng YP; Peng XL; Yu JM; Fu YH; He JS
Front Microbiol; 2022; 13():1041338. PubMed ID: 36466668
[TBL] [Abstract][Full Text] [Related]
28. Protection of calves by a prefusion-stabilized bovine RSV F vaccine.
Zhang B; Chen L; Silacci C; Thom M; Boyington JC; Druz A; Joyce MG; Guzman E; Kong WP; Lai YT; Stewart-Jones GBE; Tsybovsky Y; Yang Y; Zhou T; Baxa U; Mascola JR; Corti D; Lanzavecchia A; Taylor G; Kwong PD
NPJ Vaccines; 2017 Mar; 2():7. PubMed ID: 29021918
[TBL] [Abstract][Full Text] [Related]
29. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
30. Alternative conformations of a major antigenic site on RSV F.
Jones HG; Battles MB; Lin CC; Bianchi S; Corti D; McLellan JS
PLoS Pathog; 2019 Jul; 15(7):e1007944. PubMed ID: 31306469
[TBL] [Abstract][Full Text] [Related]
31. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.
Blais N; Gagné M; Hamuro Y; Rheault P; Boyer M; Steff AM; Baudoux G; Dewar V; Demers J; Ruelle JL; Martin D
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404847
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.
Gilman MS; Moin SM; Mas V; Chen M; Patel NK; Kramer K; Zhu Q; Kabeche SC; Kumar A; Palomo C; Beaumont T; Baxa U; Ulbrandt ND; Melero JA; Graham BS; McLellan JS
PLoS Pathog; 2015 Jul; 11(7):e1005035. PubMed ID: 26161532
[TBL] [Abstract][Full Text] [Related]
34. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.
McLellan JS; Yang Y; Graham BS; Kwong PD
J Virol; 2011 Aug; 85(15):7788-96. PubMed ID: 21613394
[TBL] [Abstract][Full Text] [Related]
35. Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
Cayatte C; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; McTamney P; Ren K; O'Day T; McCarthy MP; Schneider-Ohrum K
PLoS One; 2017; 12(11):e0188708. PubMed ID: 29182682
[TBL] [Abstract][Full Text] [Related]
36. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
37. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
Phung E; Chang LA; Mukhamedova M; Yang L; Nair D; Rush SA; Morabito KM; McLellan JS; Buchholz UJ; Mascola JR; Crank MC; Chen G; Graham BS; Ruckwardt TJ
Sci Transl Med; 2022 Jun; 14(650):eabo5032. PubMed ID: 35731888
[TBL] [Abstract][Full Text] [Related]
38. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.
McLellan JS
Curr Opin Virol; 2015 Apr; 11():70-5. PubMed ID: 25819327
[TBL] [Abstract][Full Text] [Related]
39. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656
[TBL] [Abstract][Full Text] [Related]
40. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
